Hepatitis B related liver cirrhosis
Conditions
Interventions
Control Group:Placebo
Sponsors
Shenzhen Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of traditional Chinese and Western medicine for severe liver fibrosis of hepatitis B in this study; 2. Aged 18-65 years old, without heart, brain, kidney and other diseases; 3. Those who are informed about this research, volunteer to take the test and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who do not meet the diagnostic criteria of this study; 2. Those younger than 18 years old or above 65 years old; 3. Combined with alcoholic liver disease, non-alcoholic fatty liver disease, other viral hepatitis, autoimmune liver disease, parasitic disease and other specific liver diseases that can lead to cirrhosis; 4. Combined with severe primary diseases such as cardiovascular, brain, kidney, blood system and endocrine metabolism; 5. Pregnant or breastfeeding women; 6. Those who are known to have a history of allergies to the constituents of the research drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fibrosis staging;Inflammation grade;Serum HBsAg;Serum HBeAg;Serum HBV-DNA;AFP;Fibroscan;Color Doppler ultrasound examination;Serum ALT;MicroRNA; | — |
Countries
China
Contacts
Public ContactGuangdong Tong
Shenzhen Traditional Chinese Medicine Hospital
Outcome results
None listed